International Growth Fund

    A world of investment opportunities

    Open an account
    Unit price

    $3.9427

    as at 23/12/2024
    See fund overview

    Performance chart

     

    * S&P Global LargeMidCap Index (50% hedged into NZD)

    Fund performance figures are after deductions for charges but before tax. Please note that past performance is not necessarily indicative of future returns. Returns can be positive or negative, and returns over different time periods may vary. No returns are promised or guaranteed.

    Fund highlights

    November 2024

    For the month, the International Growth Fund was up +5.2% compared to the benchmark (S&P Global LargeMidCap Index, 50% hedged into NZD) which was up +4.1%. Companies that meaningfully influenced portfolio returns were:

    Netflix (+17%) continued to rise following a positive earnings report in October, driven by strong subscriber growth and margins. The month featured the highly publicized Tyson-Paul boxing match, which drew 60 million households, and with two NFL games scheduled for Christmas Day, Netflix is positioning itself as an attractive advertising platform.

    Salesforce (+13%) benefited from improved sentiment around software stocks; and positive reception of its new AI Agentforce product. Software companies have been through a period of sluggish growth the last two years as customers digested high IT spend during COVID; and as IT budgets were shifted towards AI projects.

    Amazon (+12%) had a solid November on the back of positive third quarter earnings result. The main theme in the quarter was margins in both AWS and ecommerce. AWS recorded its highest ever quarterly operating profit margin at 38%, the result of measured spending and revenue growth reaccelerating after a period of restrained customer spending post pandemic. Amazon’s ecommerce margins continue to improve following the large investment made into its logistics infrastructure.

    Danaher (-2%) and Icon (-5%) declined on Donald Trump’s election, and also in Icon’s case, continued underperformance following its guidance downgrade last month as several large pharma customers reduced their R&D budgets and biotech spend has been slow to recover. Trump selected Robert F. Kennedy Jr. to be Health and Human Services secretary, and. while specific policies have not been announced, given his history of anti-pharma and anti-FDA rhetoric, this was seen negative for drugmakers and portfolio companies like Danaher and Icon that provide services or products to these customers.

    Portfolio Team

      Our Managed Funds

      • Conservative Fund

        Aims to provide stable returns over the long term by investing mainly in income assets with a modest allocation to growth assets.

        Learn more
      • Growth Fund

        Aims to grow your investment over the long term by investing mainly in growth assets.

        Learn more
      • Income Fund

        Aims to provide stable returns over the long term by investing in New Zealand and international fixed interest assets.

        Learn more
      • Property & Infrastructure Fund

        Focuses on growth of your investment over the long term by investing in New Zealand and international property and infrastructure assets.

        Learn more
      • New Zealand Growth Fund

        Focuses on growth of your investment over the long term by investing in quality New Zealand companies which can consistently produce increasing earnings.

        Learn more
      • Australian Growth Fund

        Focuses on growth of your investment over the long term by investing in quality Australian companies which can consistently produce increasing earnings.

        Learn more
      • International Growth Fund

        Focuses on growth of your investment over the long term by investing in quality international companies which can consistently produce increasing earnings.

        Learn more